Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.pediatrics.org/cgi/content/abstract/111/2/296

Pediatrics www.pediatric-asthma.org
Home Help [Feedback] [For Subscribers] [Browse & Search]


Full Text of this Article
Reprint (PDF) Version of this Article
P3Rs: Submit a response to this article
Similar articles found in:
Pediatrics Online
PubMed
PubMed Citation
Search Medline for articles by:
Mell, L. K. || Chen, R. T.
Alert me when:
new articles cite this article
 
Download to Citation Manager
Collections under which this article appears:
Infectious Disease & Immunity
 


PEDIATRICS Vol. 111 No. 2 February 2003, pp. 296-301

 

Polio Extraimmunization in Children Younger Than 2 Years After Changes in Immunization Recommendations

Loren K. Mell, BS*,{ddagger}, Robert L. Davis, MD, MPH*,§, John P. Mullooly, PhD||, Steven B. Black, MD, Henry R. Shinefield, MD, Kenneth M. Zangwill, MD#, Joel I. Ward, MD#, S. Michael Marcy, MD** and Robert T. Chen, MD{ddagger}{ddagger} for the CDC Vaccine Safety Datalink Project

 

* Center for Health Studies, Group Health Cooperative, Seattle, Washington
{ddagger} University of Chicago, Pritzker School of Medicine, Chicago, Illinois
§ University of Washington, Departments of Pediatrics and Epidemiology, Seattle, Washington
|| Center for Health Research, Northwest Kaiser Permanente, Portland, Oregon
Division of Research, Kaiser Permanente of Northern California, Oakland, California
# UCLA Center for Vaccine Research, Harbor-UCLA Medical Center, Torrance, California
** Kaiser-UCLA Vaccine Research Group, Southern California Kaiser, Permanente, Panorama City, California
{ddagger}{ddagger} National Immunization Program, Vaccine Safety and Development Activity, Centers for Disease Control and Prevention, Atlanta, Georgia

Objective. To investigate trends over time in polio extraimmunization among children in 4 large health maintenance organizations and to study the association with recent changes in polio immunization policy.

Methods. Using 176 169 children who were born after 1994 and enrolled for their first 2 years of life, we assessed rates and trends of polio extraimmunization in the Vaccine Safety Datalink project. We used logistic regression to test the association of extraimmunization with different polio immunization schedules and with sociodemographic characteristics and used Poisson regression to test changes in rates over time.

Results. Overall, 10.5% were extraimmunized for poliovirus; children on the all inactivated polio virus or sequential schedule were one half as likely as those on the all oral polio virus schedule to be extraimmunized by 2 years of age. There was a significant decrease in extraimmunization over time, with <5% of children born at the end of 1997 being extraimmunized, compared with >15% at the beginning of 1994.

Conclusions. Poliovirus extraimmunization rates have fallen dramatically in association with the change-over to the all inactivated polio virus schedule.

 

Key Words: extraimmunization • polio vaccine

 

Abbreviations: OPV, oral polio virus • IPV, inactivated polio virus • DTP, diphtheria and tetanus toxoids and whole-cell pertussis • DTaP, diphtheria and tetanus toxoids and acellular pertussis • Hib, Haemophilus influenzae type b • HBV, hepatitis B virus • MMR, measles-mumps-rubella • HMO, health maintenance organization • GHC, Group Health Cooperative of Puget Sound • SCK, Southern California Kaiser Permanente Health Care Program • NCK, Northern California Kaiser Permanente Health Care Program • NWK, Kaiser Permanente Northwest

 


Received for publication Jun 3, 2002; accepted Sep 23, 2002.





 

 

[For Subscribers]
Copyright © 2003 by the American Academy of Pediatrics. [Disclaimer]

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.